Bibliotecas PUC-SP - Busca Integrada

Nonalcoholic fatty liver disease and type 2 diabetes: where do Diabetologists stand?

por Shaheen Tomah, Naim Alkhouri, Osama Hamdy
Publicado en Clinical Diabetes and Endocrinology (2020-06-01)

Management of nonalcoholic fatty liver disease: Lessons learned from type 2 diabetes

por Naim Alkhouri, Fred Poordad, Eric Lawitz
Publicado en Hepatology Communications (2018-07-01)

Designing Clinical Trials in Pediatric Nonalcoholic Steatohepatitis: Tips for Patient Selection and Appropriate Endpoints

por Naim Alkhouri, Rohit Kohli, Ariel E. Feldstein
Publicado en Hepatology Communications (2019-12-01)

Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?

por Ibrahim A. Hanouneh, Naim Alkhouri, Amit G. Singal
Publicado en Clinical and Molecular Hepatology (2019-09-01)

Noninvasive Testing Using Magnetic Resonance Imaging Techniques as Outcomes in Nonalcoholic Steatohepatitis Clinical Trials: How Full Is the Glass?

por Nabil Noureddin, Jörn M. Schattenberg, Naim Alkhouri, Mazen Noureddin
Publicado en Hepatology Communications (2020-02-01)

What Does the Future Hold for Patients With Nonalcoholic Steatohepatitis: Diagnostic Strategies and Treatment Options in 2021 and Beyond?

por Naim Alkhouri, Monica Tincopa, Rohit Loomba, Stephen A. Harrison
Publicado en Hepatology Communications (2021-11-01)

The development of the pediatric NAFLD fibrosis score (PNFS) to predict the presence of advanced fibrosis in children with nonalcoholic fatty liver disease.

por Naim Alkhouri, Sana Mansoor, Paola Giammaria, Daniela Liccardo, Rocio Lopez, Valerio Nobili
Publicado en PLoS ONE (2014-01-01)

Avatrombopag, an Alternate Treatment Option to Reduce Platelet Transfusions in Patients with Thrombocytopenia and Chronic Liver Disease-Integrated Analyses of 2 Phase 3 Studies

por Fred Poordad, Norah A. Terrault, Naim Alkhouri, Wei Tian, Lee F. Allen, Mordechai Rabinovitz
Publicado en International Journal of Hepatology (2020-01-01)

Predicting NAFLD prevalence in the United States using National Health and Nutrition Examination Survey 2017–2018 transient elastography data and application of machine learning

por Mazen Noureddin, Fady Ntanios, Deepa Malhotra, Katherine Hoover, Birol Emir, Euan McLeod, Naim Alkhouri
Publicado en Hepatology Communications (2022-07-01)

Prevalence of at-risk NASH and its association with metaboMAQ:Editorial Office/AASLD: Please indicate if a visual abstract will be forthcoming for this article.lic syndrome in US a...

por Julia Y. Payne, Naim Alkhouri, Phuc Le, Michael B. Rothberg, Prido Polanco, Celine Sakkal, Srinivasan Dasarathy
Publicado en Hepatology Communications (2023-01-01)

Effects of Resmetirom on Noninvasive Endpoints in a 36‐Week Phase 2 Active Treatment Extension Study in Patients With NASH

por Stephen A. Harrison, Mustafa Bashir, Sam E. Moussa, Kevin McCarty, Juan Pablo Frias, Rebecca Taub, Naim Alkhouri
Publicado en Hepatology Communications (2021-04-01)

The prevalence of alcoholic and nonalcoholic fatty liver disease in adolescents and young adults in the United States: analysis of the NHANES database

por Naim Alkhouri, Ashraf Almomani, Phuc Le, Julia Y. Payne, Imad Asaad, Celine Sakkal, Miriam Vos, Mazen Noureddin, Prabhat Kumar
Publicado en BMC Gastroenterology (2022-07-01)

The association between perceived stress, acculturation, and non-alcoholic fatty liver disease in Mexican-origin adults in Southern Arizona

por Adriana Maldonado, Edgar A. Villavicencio, Rosa M. Vogel, Thaddeus W. Pace, John M. Ruiz, Naim Alkhouri, David O. Garcia
Publicado en Preventive Medicine Reports (2023-04-01)

The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD)-related advanced fibrosis and cirrhosis in the United States population utilizing AGILE 3 + and A...

por Naim Alkhouri, Ashraf Almomani, Phuc Le, Julia Y. Payne, Imad Asaad, Prido Polanco, Phillip Leff, Prabhat Kumar, Mazen Noureddin
Publicado en BMC Gastroenterology (2024-07-01)

A Novel Prescription Digital Therapeutic Option for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease

por Naim Alkhouri, Katherine Edwards, Mark Berman, Heather Finn, Rafael Escandon, Paul Lupinacci, Nicole Guthrie, Angie Coste, Jesus Topete, Mazen Noureddin
Publicado en Gastro Hep Advances (2024-01-01)

Noninvasive measure of treatment response in non‐alcoholic steatohepatitis: Insights from EMMINENCE and meta‐analysis

por Beth A Davison, Christopher Edwards, Rohit Loomba, Stephen A Harrison, Gad Cotter, Naim Alkhouri, Gary G Koch, Howard C Dittrich
Publicado en JGH Open (2021-07-01)

Comparison between non-alcoholic fatty liver disease screening guidelines in children and adolescents

por Yamen Ezaizi, Mohammad Nasser Kabbany, Praveen Kumar Conjeevaram Selvakumar, Muhammed Talal Sarmini, Amandeep Singh, Rocio Lopez, Valerio Nobili, Naim Alkhouri
Publicado en JHEP Reports (2019-10-01)

The Protein-Sparing Modified Fast Diet

por Marwan Bakhach MD, Vaishal Shah MD, Tara Harwood RD, Sara Lappe MD, Natalie Bhesania MD, Sana Mansoor MD, Naim Alkhouri MD
Publicado en Global Pediatric Health (2016-01-01)

Correction: Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosis.

por Naim Alkhouri, Casey Johnson, Leon Adams, Sachiko Kitajima, Chikayuki Tsuruno, Tracey L Colpitts, Kazuki Hatcho, Eric Lawitz, Rocio Lopez, Ariel E Feldstein
Publicado en PLoS ONE (2018-01-01)

Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosis.

por Naim Alkhouri, Casey Johnson, Leon Adams, Sachiko Kitajima, Chikayuki Tsuruno, Tracey L Colpitts, Kazuki Hatcho, Eric Lawitz, Rocio Lopez, Ariel E Feldstein
Publicado en PLoS ONE (2018-01-01)